Anna Grenda
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 10
- Lung Cancer Research Studies 8
-
- MicroRNA in disease regulation 7
- Co-authors
- Paweł Adam Krawczyk (37 shared papers)Janusz Milanowski (32 shared papers)Tomasz Grenda (9 shared papers)K. Kwiatek (6 shared papers)Ewa Kalinka‐Warzocha (4 shared papers)Kamila Wojas‐Krawczyk (8 shared papers)Agata Anna Filip (5 shared papers)Kamila Rybczyńska‐Tkaczyk (5 shared papers)
In The Last Decade
Anna Grenda
54 papers receiving 734 citations
Peers
Comparison fields: 5 of 98
- Cancer Research 128
- Oncology 198
- Drug Discovery 1
- Biological Psychiatry 11
- Obstetrics and Gynecology 31
Countries citing papers authored by Anna Grenda
This map shows the geographic impact of Anna Grenda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Grenda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Grenda more than expected).
Fields of papers citing papers by Anna Grenda
This network shows the impact of papers produced by Anna Grenda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Grenda. The network helps show where Anna Grenda may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Grenda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 61 | |
| 2 | 2023 | 54 | |
| 3 | 2022 | 51 | |
| 4 | 2023 | 46 | |
| 5 | 2022 | 46 | |
| 6 | 2024 | 41 | |
| 7 | 2017 | 34 | |
| 8 | 2016 | 30 | |
| 9 | 2021 | 26 | |
| 10 | 2022 | 23 | |
| 11 | 2019 | 23 | |
| 12 | 2020 | 22 | |
| 13 | 2013 | 20 | |
| 14 | 2019 | 17 | |
| 15 | 2019 | 15 | |
| 16 | 2022 | 14 | |
| 17 | 2020 | 14 | |
| 18 | 2022 | 13 | |
| 19 | 2019 | 12 | |
| 20 | 2022 | 12 |
About Anna Grenda
Anna Grenda is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Neurology, having authored 58 papers that have together received 747 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Research Studies (8 papers), MicroRNA in disease regulation (7 papers), Gut microbiota and health (5 papers), Botulinum Toxin and Related Neurological Disorders (5 papers), Cancer Research and Treatments (4 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Cancer Research (128 citations), Oncology (198 citations), Drug Discovery (1 citation), Biological Psychiatry (11 citations) and Obstetrics and Gynecology (31 citations). Anna Grenda has collaborated with scholars based in Poland, China and Germany. Frequent co-authors include Paweł Adam Krawczyk, Janusz Milanowski, Tomasz Grenda, K. Kwiatek, Ewa Kalinka‐Warzocha, Kamila Wojas‐Krawczyk, Agata Anna Filip, Kamila Rybczyńska‐Tkaczyk, Marcin Nicoś and Piotr Domaradzki. Their work appears in journals such as International Journal of Molecular Sciences, Pathogens, Cancers, Translational Lung Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.